Literature DB >> 25377773

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

Agnieszka Dyduch1, Maria Załuska2.   

Abstract

Parkinson's disease (PD) is a neurological disease with a heterogeneous pattern of neurological symptoms and concomitant psychiatric syndromes. These syndromes are triggered by alterations to neurotransmission that are likely common for both neurological and psychiatric symptoms. Syndromes such as depression, anxiety, or cognitive impairment can precede motor symptoms of PD and delay its diagnosis. Recently, questions related to aetiological factors and treatment strategies of depression in PD have become a growing concern of PD researchers. This article describes the main features of depression in PD and presents current hypotheses on its aetiology and recommended treatment modes.
© 2014 The Authors. Psychogeriatrics © 2014 Japanese Psychogeriatric Society.

Entities:  

Keywords:  Parkinson's disease; depression; pharmacotherapy

Year:  2014        PMID: 25377773     DOI: 10.1111/psyg.12078

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  2 in total

1.  Alteration of brainstem raphe measured by transcranial sonography in depression patients with or without Parkinson's disease.

Authors:  Ying Chun Zhang; Hua Hu; Wei Feng Luo; Yu Jing Sheng; Xiao Fang Chen; Cheng Jie Mao; Kang Ping Xiong; Li Fang Yu; Ying Zhang; Chun Feng Liu
Journal:  Neurol Sci       Date:  2015-08-08       Impact factor: 3.307

Review 2.  Clinical uses of Bupropion in patients with Parkinson's disease and comorbid depressive or neuropsychiatric symptoms: a scoping review.

Authors:  Matteo Vismara; Beatrice Benatti; Gregorio Nicolini; Ilaria Cova; Edoardo Monfrini; Alessio Di Fonzo; Vincenza Fetoni; Caterina A Viganò; Alberto Priori; Bernardo Dell'Osso
Journal:  BMC Neurol       Date:  2022-05-05       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.